Substrate recognition and cleavage-site preferences of Lon protease
Journal of Biological Chemistry · 2025-04 · 301 (4) · 108365
DOI: 10.1016/j.jbc.2025.108365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025-04. Verfasst von Melanie Cragan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Molecular and Cellular Biology, Department of Biochemistry and Cell Biology, Center for Infectious Diseases, Stony Brook Universi…. Hauptthemen laut MEDLINE: Protease La, Yersinia pestis, Bacterial Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases.
Abstract (Originalsprache)
The evolutionarily conserved AAA+ Lon protease plays a pivotal role in protein homeostasis by precisely remodeling the proteome and specifically removing unfolded, damaged, and surplus natively folded regulatory proteins. Proteolysis by Lon comprises the three fundamental stages of substrate recognition via specific amino acid sequence motifs (degrons), ATP-fueled substrate unfolding and translocation into a sequestered proteolytic chamber, and cleavage of the translocated polypeptide by the peptidase domain. Although a plethora of Lon substrates have been identified in several bacterial species, broadly applicable rules that govern recognition of numerous substrates, and hence the ability to de novo identify new Lon substrates and regulatory pathways, has lagged behind. Similarly, cleavage-site preferences of Lon proteases, and whether these crucial enzymes from diverse bacterial species share similar preferences, have remained underexplored. In this study, we report the identification and characterization of a class of high-affinity autonomous C-terminal Yersinia pestis Lon recognition degrons, variants of which are present in numerous known and new Yersinia pestis-Lon substrates and broadly distributed in diverse bacterial species. Moreover, the identification of this degron group offers the predictive power to discover new Lon substrates in eubacteria. Furthermore, cleavage-site preference analyses of multiple Lon substrates reveal that the Lon peptidase domain preferentially cleaves translocated polypeptides after phenylalanine residues to generate peptides that range from 7 to 35 residues, with an average length of 11 residues, a general feature conserved among Lon proteases from phylogenetically distinct bacterial species.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Molecular and Cellular Biology, Department of Biochemistry and Cell Biology, Center for Infectious Diseases, Stony Brook University, Stony Brook, New York, USA.
- Graduate Program in Molecular and Cellular Biology, Department of Biochemistry and Cell Biology, Center for Infectious Diseases, Stony Brook University, Stony Brook, New York, USA. Electronic address: wali.karzai@stonyb…
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases
- National Institutes of Health
- NIH National Institute of General Medical Sciences
Zitieren
APA
Cragan, M., Puri, N., & Karzai, A. W. (2025). Substrate recognition and cleavage-site preferences of Lon protease. Journal of Biological Chemistry, 301(4), 108365. https://doi.org/10.1016/j.jbc.2025.108365
Vancouver
Cragan M, Puri N, Karzai AW. Substrate recognition and cleavage-site preferences of Lon protease. Journal of Biological Chemistry. 2025;301(4):108365. doi:10.1016/j.jbc.2025.108365
BibTeX
@article{Cragan2025,
author = {Cragan, Melanie and Puri, Neha and Karzai, A Wali},
title = {Substrate recognition and cleavage-site preferences of Lon protease},
journal = {Journal of Biological Chemistry},
year = {2025},
volume = {301},
number = {4},
pages = {108365},
doi = {10.1016/j.jbc.2025.108365}
}
EUVIMED